A detailed history of Nomura Holdings Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 36,451 shares of VIR stock, worth $205,219. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,451
Previous 17,105 113.1%
Holding current value
$205,219
Previous $86,000 141.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$4.28 - $5.93 $82,800 - $114,721
19,346 Added 113.1%
36,451 $208,000
Q2 2025

Aug 18, 2025

SELL
$4.5 - $6.48 $24,984 - $35,976
-5,552 Reduced 24.5%
17,105 $86,000
Q2 2025

Aug 14, 2025

BUY
$4.5 - $6.48 $101,956 - $146,817
22,657 New
22,657 $114,000

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $747M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.